“Pharma & Energy Exchange: Winners & Losers”

gained ~2.5% after announcing a generic obesity drug launch in 87 countries next year 🚀, while nosedived ~15% following new market-coupling concerns. 💡 Takeaway: Defense from global themes and sector shifts—pharma stays resilient, while power exchanges face uncertainty.